YOUR BUSINESS AUTHORITY
Springfield, MO
A weight-loss treatment from Eli Lilly has been given regulatory approval by the United States and United Kingdom.
Zepbound is expected to hit store shelves in the United States later this month.
Zepbound reportedly will be a rival to Novo Nordisk's Wegovy treatment.
Read more from Reuters.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
Trump, fast-food companies among targets of X redirects
Stockton district names next superintendent
State awards Springfield $4.6M for wastewater system improvements
Council modifies data center definitions bill, extends moratorium into next year